Zota Health Care LImited - Asset Resilience Ratio

Latest as of March 2025: 0.68%

Zota Health Care LImited (ZOTA) has an Asset Resilience Ratio of 0.68% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs29.74 Million

≈ $321.63K USD Cash + Short-term Investments

Total Assets

Rs4.39 Billion

≈ $47.49 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Zota Health Care LImited's Asset Resilience Ratio has changed over time. Check Zota Health Care LImited PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Zota Health Care LImited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Zota Health Care LImited.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs14.87 Million	0.34%
Short-term Investments	Rs14.87 Million	0.34%
Total Liquid Assets	Rs29.74 Million	0.68%

Asset Resilience Insights

Limited Liquidity: Zota Health Care LImited maintains only 0.68% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Zota Health Care LImited Industry Peers by Asset Resilience Ratio

Compare Zota Health Care LImited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Zota Health Care LImited (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Zota Health Care LImited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.68%	Rs29.74 Million ≈ $321.63K	Rs4.39 Billion ≈ $47.49 Million	+0.39pp
2024-03-31	0.29%	Rs6.56 Million ≈ $70.94K	Rs2.28 Billion ≈ $24.69 Million	-1.01pp
2023-03-31	1.29%	Rs20.46 Million ≈ $221.29K	Rs1.58 Billion ≈ $17.10 Million	-1.96pp
2022-03-31	3.25%	Rs45.22 Million ≈ $489.02K	Rs1.39 Billion ≈ $15.04 Million	+0.16pp
2021-03-31	3.09%	Rs26.39 Million ≈ $285.35K	Rs854.69 Million ≈ $9.24 Million	+1.26pp
2020-03-31	1.83%	Rs16.21 Million ≈ $175.29K	Rs884.79 Million ≈ $9.57 Million	+1.83pp
2019-03-31	0.00%	Rs120.00 ≈ $1.30	Rs896.07 Million ≈ $9.69 Million	+0.22pp
2018-03-31	-0.22%	Rs-2.00 Million ≈ $-21.63K	Rs917.94 Million ≈ $9.93 Million	+0.03pp
2016-03-31	-0.24%	Rs-1.08 Million ≈ $-11.63K	Rs440.52 Million ≈ $4.76 Million	--

pp = percentage points

About Zota Health Care LImited

NSE:ZOTA India Biotechnology

Market Cap

$415.20 Million

Rs38.39 Billion INR

Market Cap Rank

#13097 Global

#673 in India

Share Price

Rs1265.70

Change (1 day)

-1.06%

52-Week Range

Rs1043.10 - Rs1687.00

All Time High

Rs1687.00